PF-Atlas › Clinical Trials › NCT01883531

Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years

Inhaled Mannitol · Phase 2

Registry ID
NCT01883531
Phase
Phase 2
Status
Completed
Drug / intervention
Inhaled Mannitol
Sponsor
Syntara
Start
2013-06

About this trial

Inhaled Mannitol is evaluated in NCT01883531, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Syntara. Current status: Completed.

View NCT01883531 on ClinicalTrials.gov →

Explore related

All Inhaled Mannitol trialsAll IPF trials

Related trials

Inhaled mannitol — NCT00669331Inhaled mannitol — NCT02134353Inhaled mannitol — NCT00455130inhaled mannitol — NCT00630812
Medical disclaimer. This page summarizes public trial data for NCT01883531 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.